Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
House of Kush is a cannabis genetics and lifestyle company focused on bringing iconic, legacy cannabis strains to the legal global marketplace. The company specializes in the identification, curation, and licensing of high-quality cannabis genetics, most notably the Bubba Kush lineage. By partnering with licensed producers and multi-state operators, House of Kush ensures that authentic, premium cannabis products are available to both medical and recreational consumers. Their business model centers on intellectual property licensing, brand development, and the standardization of cultivars within the evolving legal cannabis landscape. The company bridges the gap between legacy cannabis culture and modern pharmaceutical-grade botanical standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on House of Kush.